Digital Guide: PARP Inhibitors for Ovarian Cancer - Portland

Ovarian cancer specialists around the country are increasingly excited about the new treatment possibility of PARP inhibitors, and one reason is that more and more research is finding that there is some benefit for almost all patients.

To determine when — and whether — you are eligible for one of these promising drugs, your gynecologic oncologist will likely recommend a series of tests to see whether your cancer cells have the right characteristics, and to what degree.

PARP inhibitors are beneficial for many women with ovarian cancer as a form of maintenance therapy, but not every woman should take them. This class of drugs can come with some pretty serious side effects.